(Business Wire India; 5th June, 2014); Kinetic Concepts, Inc. announced today that a new study, published in the International Wound Journal, showed the Prevena™ Incision Management System used over closed incisions for the first six to seven days reported a significantly lower infection rate than conventional dressings in patients undergoing cardiac surgery via median sternotomy. Post-sternotomy wound infection is a serious, potentially fatal complication of cardiac surgery which often requires additional surgery, and is associated with significantly increased health care costs.
(Business Wire India; 3rd June, 2014); Bristol-Myers Squibb and Syngene International, India’s largest contract research organization, today announced a five-year extension of their drug discovery and development collaboration in India. Financial terms were not disclosed.
Since 2007, Bristol-Myers Squibb has been working with Syngene and its corporate parent, Biocon Ltd., to develop integrated capabilities in medicinal and process chemistry, biology, biotechnology, biomarkers, drug metabolism and pharmacokinetics, analytical research, and pharmaceutical development at the Biocon Bristol-Myers Squibb Research Center (BBRC) in Bangalore.
(1st June, 2014); Dr Harsh Vardhan, Union Minister for Health and Family Welfare, has asked for thorough streamlining of systems in the distribution of free generic drugs to government health institutions at all levels throughout the country. The Free Drug Programme’s formal launch would be preceded by working out all logistical details with respect to procurement and distribution in consultation with the state governments.
(Business Wire India; 28th May, 2014); Colgate-Palmolive (India) Limited, the market leader in Oral Care, launched a toothpaste with first of its kind technology – Colgate Maximum Cavity Protection Plus Sugar Acid Neutralizer TM.
(22nd May, 2014);The U.S. Food and Drug Administration (FDA) approved the Immucor PreciseType Human Erythrocyte Antigen (HEA) Molecular BeadChip Test (BeadChip Test), manufactured by BioArray Solutions Ltd. of Warren, New Jersey, the first FDA-approved molecular assay used in transfusion medicine to assist in determining blood compatibility. The assay can be used to determine donor and patient non-ABO/non-RhD (non-ABO) red blood cell (RBC) types in the United States.
(Business Wire India; 20th May, 2014); Wipro Ltd., a leading global Information Technology, Consulting and Outsourcing company today announced a strategic partnership with Takeda Pharmaceutical Company Ltd., the largest pharmaceutical company in Japan and one of the global leaders of the industry.
(Business Wire India; 19th May, 2014); Ferring Pharmaceuticals marks World IBD Day (May 19th) with the launch of Guts4life (guts4life.com), a new interactive website with information, support and inspiration for people concerned with Crohn’s disease and ulcerative colitis, conditions known as inflammatory bowel diseases (IBD). IBD describes a range of chronic diseases of the gastrointestinal system characterised by intermittent flares with debilitating symptoms that can affect a patient’s quality of life and lead to emotional distress and social isolation. Guts4life was designed together with IBD patients to provide support and encouragement throughout the IBD journey—from bowel symptom worries, to diagnosis, through managing and living with IBD.
(15th May, 2014); Researchers from Center of Advanced European Studies and the University Department of Growth and Reproduction find out large amount of endocrine-disrupting chemicals interfere with human sperm function and that may have a negative impact on fertilization. The study indicates that the chemicals might evoke changes in swimming behaviour at the wrong time and wrong place, hinder navigation of sperm towards the egg and hamper penetration into the protective egg coat.
(15th May, 2014); Researchers have shown that neurons generated from the skin cells of people with schizophrenia behave unfamiliar in early developmental stages. They used new stem cell research technology for same and they believe that this research may provide new ideas to detect and potentially cure the disease early.
(14th May, 2014); Today, the Wellcome Trust has signed a concordat on openness on animal research in the UK. There are 72 other organisations across the scientific sector, including universities, charities, commercial companies, research councils, umbrella bodies and learned societies are joining in concordat.